Search Results - Vincent O’Neill

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC phenotype

    661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC phenoty... by Vincent O’Neill, Veena Agarwal, Moses K Donkor, Sherry Kupchick, Rashmi Deshpande, Dawn Newmin

    Published 2023-11-01
    Article
    Save to List
    Saved in:
  2. 2
    382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study

    382 Targeting innate immunity with BXCL701 in combination with pembrolizumab in patients with advanced solid cancers: phase 2 basket study by Filip Janku, Apostolia Tsimberidou, Diane Healey, Vincent O’Neill, Veronica Holley, Abha Adat, Ozgur Karakuzu, Greg Call, Gabriele Urschel

    Published 2020-11-01
    Article
    Save to List
    Saved in:
  3. 3
    1478 Dipeptidyl peptidase 4 (DPP4) inhibition is not solely responsible for the anti-tumor effects of BXCL701, an inhibitor of multiple DPPs, in a murine model of pancreatic ductal adenocarcinoma

    1478 Dipeptidyl peptidase 4 (DPP4) inhibition is not solely responsible for the anti-tumor effects of BXCL701, an inhibitor of multiple DPPs, in a murine model of pancreatic ductal... by Vincent O’Neill, Veena Agarwal, Annie Zuo, Sandra A Jablonski, Louis M Weiner, Alexander Lekan, Rachael Maynard, Zoe X Malchiodi, Moses Donkor

    Published 2023-11-01
    Article
    Save to List
    Saved in:

Search Tools: